https://adisinsight.springer.com/drugs/800086789?error=cookies_not_supported&code=dc68bfb6-4c77-41ca-add5-10cb3f36633e
SIRP NNP ASO - SHIFTBIO - AdisInsight
SIRP NNP ASO is a targeted antisense oligonucleotide therapy, being developed by SHIFTBIO utilizing its NSM platform, for the treatment of inflammatory bowel
sirpnnpasoadisinsight